A detailed history of True Wealth Design, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, True Wealth Design, LLC holds 269 shares of EXAS stock, worth $16,239. This represents 0.01% of its overall portfolio holdings.

Number of Shares
269
Previous 306 12.09%
Holding current value
$16,239
Previous $12.9 Million 41.74%
% of portfolio
0.01%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$42.43 - $70.83 $1,569 - $2,620
-37 Reduced 12.09%
269 $18.3 Million
Q2 2024

Aug 14, 2024

BUY
$41.33 - $74.26 $12,399 - $22,278
300 Added 5000.0%
306 $12.9 Million
Q1 2024

May 14, 2024

BUY
$56.27 - $73.77 $168 - $221
3 Added 100.0%
6 $415,000
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $37,608 - $57,030
-600 Reduced 99.5%
3 $282,000
Q1 2023

May 12, 2023

BUY
$47.19 - $70.77 $47 - $70
1 Added 0.17%
603 $40.9 Million
Q4 2022

Feb 15, 2023

BUY
$30.35 - $53.15 $18,270 - $31,996
602 New
602 $29.8 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.7B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.